NO20034414L - Use of N-phenyl-2-pyrimidinamine derivatives against mast cell-based diseases such as allergic disorders - Google Patents

Use of N-phenyl-2-pyrimidinamine derivatives against mast cell-based diseases such as allergic disorders

Info

Publication number
NO20034414L
NO20034414L NO20034414A NO20034414A NO20034414L NO 20034414 L NO20034414 L NO 20034414L NO 20034414 A NO20034414 A NO 20034414A NO 20034414 A NO20034414 A NO 20034414A NO 20034414 L NO20034414 L NO 20034414L
Authority
NO
Norway
Prior art keywords
phenyl
mast cell
allergic disorders
based diseases
derivatives against
Prior art date
Application number
NO20034414A
Other languages
Norwegian (no)
Other versions
NO325454B1 (en
NO20034414D0 (en
Inventor
Kenichi Koike
Atsushi Komiyama
Kovichi Takeuchi
Original Assignee
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Veterans Affairs filed Critical Us Gov Veterans Affairs
Publication of NO20034414D0 publication Critical patent/NO20034414D0/en
Publication of NO20034414L publication Critical patent/NO20034414L/en
Publication of NO325454B1 publication Critical patent/NO325454B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20034414A 2001-04-05 2003-10-02 Use of N- {5- [4- (4-methyl-piperazino-methyl) -benzoylamido] -2-methylphenyl} -4- (3-pyridyl) -2-pyrimidine-amine. NO325454B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108606.5A GB0108606D0 (en) 2001-04-05 2001-04-05 Organic compounds
PCT/US2002/010742 WO2002080925A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Publications (3)

Publication Number Publication Date
NO20034414D0 NO20034414D0 (en) 2003-10-02
NO20034414L true NO20034414L (en) 2003-12-04
NO325454B1 NO325454B1 (en) 2008-05-05

Family

ID=9912339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034414A NO325454B1 (en) 2001-04-05 2003-10-02 Use of N- {5- [4- (4-methyl-piperazino-methyl) -benzoylamido] -2-methylphenyl} -4- (3-pyridyl) -2-pyrimidine-amine.

Country Status (18)

Country Link
EP (1) EP1389113A1 (en)
KR (2) KR20090034998A (en)
CN (1) CN1529602A (en)
AU (1) AU2002307140B2 (en)
BR (1) BR0208663A (en)
CA (1) CA2443092A1 (en)
CZ (1) CZ20032705A3 (en)
GB (1) GB0108606D0 (en)
HU (1) HUP0303751A3 (en)
IL (1) IL158061A0 (en)
MX (1) MXPA03009058A (en)
NO (1) NO325454B1 (en)
NZ (1) NZ528934A (en)
PL (1) PL363080A1 (en)
RU (1) RU2304436C2 (en)
SK (1) SK12312003A3 (en)
WO (1) WO2002080925A1 (en)
ZA (1) ZA200307563B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2266553T3 (en) 2001-06-29 2007-03-01 Ab Science USE OF N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES TO TREAT INFLAMMATORY DISEASES.
WO2003003006A2 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
JP2004537542A (en) 2001-06-29 2004-12-16 アブ サイエンス Use of a tyrosine kinase inhibitor for treating inflammatory bowel disease (IBD)
ES2274993T3 (en) 2001-06-29 2007-06-01 Ab Science USE OF THYROSINE KINASE INHIBITORS FOR THE TREATMENT OF ALLERGIC DISEASES.
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
CA2479257A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
MXPA05001277A (en) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors.
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
GB2398565A (en) * 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
CA2517308A1 (en) * 2003-02-27 2004-09-10 Ab Science Tailored treatment suitable for different forms of mastocytosis
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
JP2008510766A (en) * 2004-08-27 2008-04-10 ゲーペーツェー ビオテック アーゲー Pyrimidine derivatives
CA2606716C (en) * 2005-05-02 2013-07-23 Novartis Ag Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis
KR100845278B1 (en) * 2006-08-04 2008-07-09 포항공과대학교 산학협력단 Peptides Inducing Activity of Mast Cells and Immune Modulators Comprising the Same
AU2010235334A1 (en) * 2009-04-06 2011-11-24 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing burn injuries
CN103058935B (en) * 2013-01-15 2015-05-06 四川大学 Pyrimidine compound as well as preparation method and use for same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (en) * 1997-07-18 2000-07-24 Novartis Ag MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE

Also Published As

Publication number Publication date
GB0108606D0 (en) 2001-05-23
ZA200307563B (en) 2004-04-21
AU2002307140B2 (en) 2006-02-16
RU2304436C2 (en) 2007-08-20
EP1389113A1 (en) 2004-02-18
KR20040007485A (en) 2004-01-24
WO2002080925A1 (en) 2002-10-17
KR20090034998A (en) 2009-04-08
NZ528934A (en) 2006-10-27
RU2003130635A (en) 2005-02-10
MXPA03009058A (en) 2004-11-22
PL363080A1 (en) 2004-11-15
IL158061A0 (en) 2004-03-28
NO325454B1 (en) 2008-05-05
CA2443092A1 (en) 2002-10-17
HUP0303751A3 (en) 2005-06-28
BR0208663A (en) 2004-03-09
CN1529602A (en) 2004-09-15
CZ20032705A3 (en) 2004-06-16
SK12312003A3 (en) 2004-02-03
HUP0303751A2 (en) 2005-04-28
NO20034414D0 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
NO20034414L (en) Use of N-phenyl-2-pyrimidinamine derivatives against mast cell-based diseases such as allergic disorders
NO20043158L (en) Substituted quinazoline derivatives as inhibitors of aurorakinases
NO20042842L (en) Pharmaceutical formulations of platinum derivative
NO20034523L (en) Pyrazole derivatives for the treatment of HIV
NO20042279L (en) Quinazoline derivatives as antitumor agents
NO20042288L (en) Quinazoline derivatives as antitumor agents
HUS1500048I1 (en) Local formulation of Ivermectin for the treatment of dermatological conditions
EE200300359A (en) Composition and antiviral activity of substituted azaindole oxoacetypiperazine derivatives
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
CY2017048I2 (en) NEW PHARMACEUTICAL USES OF STAVROSPORINE DERIVATIVES
ATE353627T1 (en) STABILIZED ORAL SUSPENSION FORMULATION
NO20044916L (en) Preparations of sulfinylacetamide
AU2003255982A1 (en) Preparation of microcapsules
EP1585519A4 (en) HIGHLY CONCENTRATED FORMULATIONS OF OPIOIDES AND OPIOD DERIVATIVES
NO20041968L (en) Use of cystationin
DK1475379T3 (en) Use of scopin ester derivatives for the manufacture of drugs
AU2003209647A1 (en) Optical measurements of patterned structures
PT1392670E (en) SUBSTITUTED DERIVATIVES OF C-FURAN-2-IL-METHYLAMINE AND C-THIOFEN-2-IL-METHYLAMINE
NO20015033D0 (en) Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokines
DK1373249T3 (en) Imidazolidine derivatives, their preparation and their use as an anti-inflammatory agent
PT1385512E (en) USE OF PYRIDINDOLONE DERIVATIVES FOR THE PREPARATION OF ANTICANCERIGENE MEDICINES
HK1062890A (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
ATE423107T1 (en) NITROOXY DERIVATIVES OF BLOOD PRESSURE LOWERING DRUGS
ITMI20041199A1 (en) COMPOUNDS OF DYES AND THEIR USE
DE60216321D1 (en) 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINOÄ4,5-BÜINDOL-1-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees